Global Statistics

All countries
178,203,523
Confirmed
Updated on June 18, 2021 12:27 am
All countries
160,989,570
Recovered
Updated on June 18, 2021 12:27 am
All countries
3,857,939
Deaths
Updated on June 18, 2021 12:27 am
Friday, June 18, 2021

Global Statistics

All countries
178,203,523
Confirmed
Updated on June 18, 2021 12:27 am
All countries
160,989,570
Recovered
Updated on June 18, 2021 12:27 am
All countries
3,857,939
Deaths
Updated on June 18, 2021 12:27 am
Molderizer and Safe Shield

Black fungus complicates India’s COVID pandemic

Vaccinations slow; Michigan rolling back restrictions

Rates of COVID-19 vaccinations are continuing to slow across the United States, data from the Centers for Disease Control and Prevention shows.In the past...

Coronavirus latest: US plans to invest over $3bn to develop Covid-19 antiviral pills

New claims for US unemployment benefits unexpectedly rose back above 400,000 last week from a pandemic-era low, though the labour market is expected...

The Lab-Leak Theory: Inside the Fight to Uncover COVID-19’s Origins

I. A Group Called DRASTICGilles Demaneuf is a data scientist with the Bank of New Zealand in Auckland. He was diagnosed with Asperger’s...

COVID-19 infections in US climbing again

COVID-19 infections in the United States are climbing again, even as Washington pushes ahead with an extensive vaccination drive. Inoculations have been ... source

UNC Researchers Lead Study of Diabetes Treatment of COVID-19 Patients

Newswise — CHAPEL HILL, NC -- Diabetes is one of the comorbidities most strongly associated with severe coronavirus disease 2019 (COVID-19) in the...


India faces a global health crisis as the number of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections reaches over 23.7 million. As the country’s health system buckles with increased admissions and a lack of resources, another health threat has emerged.

Public health officials report a rare black fungus infection, called mucormycosis, which is increasingly seen in vulnerable patients, including those with COVID-19 disease.

Mucormycosis: Broad, wide-angle non-septate hyphae of the fungus Mucor, from the paranasal sinus of a patient with diabetes mellitus. Image Credit: David A Litman / Shutterstock

Mucormycosis: Broad, wide-angle non-septate hyphae of the fungus Mucor, from the paranasal sinus of a patient with diabetes mellitus. Image Credit: David A Litman / Shutterstock

What is mucormycosis?

Mucormycosis is a very serious and potentially fatal infection caused by exposure to mucor mold. Mucor is a microbial genus of approximately 40 species of molds commonly found in soil, plants, decaying fruits and vegetables, and manure.

The fungal infection commonly affects the sinuses of the lungs after inhaling fungal spores from the air. The fungi can also enter the skin after a cut, burn, or skin injury.

The mortality rate of this infection is about 50 percent. It impacts high-risk populations due to their reduced immune system function, including those with diabetes, cancer, and human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS).

Mucormycosis may cause symptoms like coughing out blood, blackening over the nose, blurred vision, chest pain, and breathing difficulties. A classic feature of this infection is tissue necrosis or tissue death. If the fungus spreads to the eyes, the patient may develop blurred vision, drooping eyelids, swelling, and possible vision loss.

The fungal infection is not contagious and does not spread between people and animals. There is no vaccine to prevent the infection.

India and the fungal infection

India sees an increase in mucormycosis cases, partly because many people grapple with SARS-CoV-2 infection. The COVID-19 pandemic created conditions for the infection to thrive and spread. The immune system of residents is compromised by SARS-CoV-2, allowing the black fungi to take hold.

The black fungus impacts the health of people with comorbidities, like diabetes and weakened immune systems. One of the ways COVID-19 is being treated is through high-dose steroids to treat inflammation. However, the drug can suppress the immune system, making it easier for other pathogens to take advantage.

As two infections continue to wreak havoc, India’s health care system is on the brink of collapse.

In the western state of Maharashtra, including Mumbai, doctors report that around 200 patients who had recovered from COVID-19 were being treated for mucormycosis. Of these patients, eight died.

Meanwhile, in Gujarat, the local government ordered the allocation of separate wards in hospitals. Further, the officials ordered 5,000 doses of amphotericin B, the drug used to treat the fungal infection. New Delhi also reported cases of mucormycosis.

India has not released national data on the new infections but said there is no major outbreak.

Threat for diabetics

Mucormycosis may become potentially fatal in some individuals, including diabetics. The fungal infection is known to attack people who have compromised immune systems, especially those with diabetes.

People who have diabetes have weakened immune systems, making it easier for the fungi to cause infection. Apart from this, diabetics are at a higher risk of mucormycosis since the fungi love iron-rich, acidic environments, and diabetic ketoacidosis, a condition in diabetics that causes the blood to become acidic.

How to prevent mucormycosis infection?

Due to its increased fatality rate, people should be proactive in protecting themselves. They should avoid areas with dust, including excavation and construction sites. Avoid contact with water-damaged buildings and floodwater and prevent joining activities that involve close contact with soil and dust. When handling soil, make sure to use protective gloves and wash the hands with soap and water.

In treating fungal infection, patients need to receive treatment promptly. Usually, antifungal drugs will be given to kill the fungi.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular

Vaccinations slow; Michigan rolling back restrictions

Rates of COVID-19 vaccinations are continuing to slow across the United States, data from the Centers for Disease Control and Prevention shows.In the past...

Coronavirus latest: US plans to invest over $3bn to develop Covid-19 antiviral pills

New claims for US unemployment benefits unexpectedly rose back above 400,000 last week from a pandemic-era low, though the labour market is expected...

The Lab-Leak Theory: Inside the Fight to Uncover COVID-19’s Origins

I. A Group Called DRASTICGilles Demaneuf is a data scientist with the Bank of New Zealand in Auckland. He was diagnosed with Asperger’s...

Related Articles

Vaccinations slow; Michigan rolling back restrictions

Rates of COVID-19 vaccinations are continuing to slow across the United States, data from the Centers for Disease Control and Prevention shows.In the past...

Coronavirus latest: US plans to invest over $3bn to develop Covid-19 antiviral pills

New claims for US unemployment benefits unexpectedly rose back above 400,000 last week from a pandemic-era low, though the labour market is expected...

The Lab-Leak Theory: Inside the Fight to Uncover COVID-19’s Origins

I. A Group Called DRASTICGilles Demaneuf is a data scientist with the Bank of New Zealand in Auckland. He was diagnosed with Asperger’s...